Overexpression of HRad17 mRNA in human breast cancer

Correlation with lymph node metastasis

Akemi Kataoka, Noriaki Sadanaga, Masaki Mori, Koshi Mimori, Hiroaki Ueo, Graham F. Barnard, Daniel Auclair, Lan B. Chen, Keizo Sugimachi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose: A novel human gene, designated HRad17, was identified as the human homologue of the Rad17 of Schizosaccharomyces pombe and Rad24 of Saccharomyces cerevisiae. In yeast, these genes play a critical role in maintaining genomic stability. The aim of this study was to evaluate the expression of HRad17 in human breast cancer. Experimental Design: We investigated HRad17 mRNA expression in 64 cases of human breast cancer by means of reverse-transcription-PCR, in situ hybridization, and immunohistochemistry. Results: The HRad17 mRNA was overexpressed in 35 cases (54.7%). Twenty-four (68.6%) of 35 cases with HRad17 overexpression in cancer tissues were node-positive, whereas only 8 (27.6%) of 29 cases without HRad17 overexpressions were node-positive. The expression of HRad17 mRNA correlated with both lymph node metastasis (P = 0.001) and high Ki67 labeling index (P = 0.006). Although not significantly different, expression of HRad17 mRNA tended to correlate with tumor size (P = 0.06) and expression of mutant p53 protein (P = 0.10). Furthermore, expression of HRad17 mRNA was an independent predictor of axillary lymph node metastasis as well as of lymphatic permeation by multivariate analysis (P < 0.0001). Conclusions: Our study demonstrates that HRad17 might be related to the development of lymph node metastasis in human breast cancers. Although its function still remains unclear, the expression of HRad17 mRNA could open up a new window for the diagnostic staging and treatment of human breast cancers.

Original languageEnglish
Pages (from-to)2815-2820
Number of pages6
JournalClinical Cancer Research
Volume7
Issue number9
Publication statusPublished - Jan 1 2001

Fingerprint

Lymph Nodes
Breast Neoplasms
Neoplasm Metastasis
Messenger RNA
Schizosaccharomyces
Genomic Instability
Mutant Proteins
Genes
Reverse Transcription
In Situ Hybridization
Saccharomyces cerevisiae
Neoplasms
Research Design
Multivariate Analysis
Yeasts
Immunohistochemistry
Polymerase Chain Reaction
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Kataoka, A., Sadanaga, N., Mori, M., Mimori, K., Ueo, H., Barnard, G. F., ... Sugimachi, K. (2001). Overexpression of HRad17 mRNA in human breast cancer: Correlation with lymph node metastasis. Clinical Cancer Research, 7(9), 2815-2820.

Overexpression of HRad17 mRNA in human breast cancer : Correlation with lymph node metastasis. / Kataoka, Akemi; Sadanaga, Noriaki; Mori, Masaki; Mimori, Koshi; Ueo, Hiroaki; Barnard, Graham F.; Auclair, Daniel; Chen, Lan B.; Sugimachi, Keizo.

In: Clinical Cancer Research, Vol. 7, No. 9, 01.01.2001, p. 2815-2820.

Research output: Contribution to journalArticle

Kataoka, A, Sadanaga, N, Mori, M, Mimori, K, Ueo, H, Barnard, GF, Auclair, D, Chen, LB & Sugimachi, K 2001, 'Overexpression of HRad17 mRNA in human breast cancer: Correlation with lymph node metastasis', Clinical Cancer Research, vol. 7, no. 9, pp. 2815-2820.
Kataoka, Akemi ; Sadanaga, Noriaki ; Mori, Masaki ; Mimori, Koshi ; Ueo, Hiroaki ; Barnard, Graham F. ; Auclair, Daniel ; Chen, Lan B. ; Sugimachi, Keizo. / Overexpression of HRad17 mRNA in human breast cancer : Correlation with lymph node metastasis. In: Clinical Cancer Research. 2001 ; Vol. 7, No. 9. pp. 2815-2820.
@article{9aa44accfe6441d9a448c8e728990311,
title = "Overexpression of HRad17 mRNA in human breast cancer: Correlation with lymph node metastasis",
abstract = "Purpose: A novel human gene, designated HRad17, was identified as the human homologue of the Rad17 of Schizosaccharomyces pombe and Rad24 of Saccharomyces cerevisiae. In yeast, these genes play a critical role in maintaining genomic stability. The aim of this study was to evaluate the expression of HRad17 in human breast cancer. Experimental Design: We investigated HRad17 mRNA expression in 64 cases of human breast cancer by means of reverse-transcription-PCR, in situ hybridization, and immunohistochemistry. Results: The HRad17 mRNA was overexpressed in 35 cases (54.7{\%}). Twenty-four (68.6{\%}) of 35 cases with HRad17 overexpression in cancer tissues were node-positive, whereas only 8 (27.6{\%}) of 29 cases without HRad17 overexpressions were node-positive. The expression of HRad17 mRNA correlated with both lymph node metastasis (P = 0.001) and high Ki67 labeling index (P = 0.006). Although not significantly different, expression of HRad17 mRNA tended to correlate with tumor size (P = 0.06) and expression of mutant p53 protein (P = 0.10). Furthermore, expression of HRad17 mRNA was an independent predictor of axillary lymph node metastasis as well as of lymphatic permeation by multivariate analysis (P < 0.0001). Conclusions: Our study demonstrates that HRad17 might be related to the development of lymph node metastasis in human breast cancers. Although its function still remains unclear, the expression of HRad17 mRNA could open up a new window for the diagnostic staging and treatment of human breast cancers.",
author = "Akemi Kataoka and Noriaki Sadanaga and Masaki Mori and Koshi Mimori and Hiroaki Ueo and Barnard, {Graham F.} and Daniel Auclair and Chen, {Lan B.} and Keizo Sugimachi",
year = "2001",
month = "1",
day = "1",
language = "English",
volume = "7",
pages = "2815--2820",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Overexpression of HRad17 mRNA in human breast cancer

T2 - Correlation with lymph node metastasis

AU - Kataoka, Akemi

AU - Sadanaga, Noriaki

AU - Mori, Masaki

AU - Mimori, Koshi

AU - Ueo, Hiroaki

AU - Barnard, Graham F.

AU - Auclair, Daniel

AU - Chen, Lan B.

AU - Sugimachi, Keizo

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Purpose: A novel human gene, designated HRad17, was identified as the human homologue of the Rad17 of Schizosaccharomyces pombe and Rad24 of Saccharomyces cerevisiae. In yeast, these genes play a critical role in maintaining genomic stability. The aim of this study was to evaluate the expression of HRad17 in human breast cancer. Experimental Design: We investigated HRad17 mRNA expression in 64 cases of human breast cancer by means of reverse-transcription-PCR, in situ hybridization, and immunohistochemistry. Results: The HRad17 mRNA was overexpressed in 35 cases (54.7%). Twenty-four (68.6%) of 35 cases with HRad17 overexpression in cancer tissues were node-positive, whereas only 8 (27.6%) of 29 cases without HRad17 overexpressions were node-positive. The expression of HRad17 mRNA correlated with both lymph node metastasis (P = 0.001) and high Ki67 labeling index (P = 0.006). Although not significantly different, expression of HRad17 mRNA tended to correlate with tumor size (P = 0.06) and expression of mutant p53 protein (P = 0.10). Furthermore, expression of HRad17 mRNA was an independent predictor of axillary lymph node metastasis as well as of lymphatic permeation by multivariate analysis (P < 0.0001). Conclusions: Our study demonstrates that HRad17 might be related to the development of lymph node metastasis in human breast cancers. Although its function still remains unclear, the expression of HRad17 mRNA could open up a new window for the diagnostic staging and treatment of human breast cancers.

AB - Purpose: A novel human gene, designated HRad17, was identified as the human homologue of the Rad17 of Schizosaccharomyces pombe and Rad24 of Saccharomyces cerevisiae. In yeast, these genes play a critical role in maintaining genomic stability. The aim of this study was to evaluate the expression of HRad17 in human breast cancer. Experimental Design: We investigated HRad17 mRNA expression in 64 cases of human breast cancer by means of reverse-transcription-PCR, in situ hybridization, and immunohistochemistry. Results: The HRad17 mRNA was overexpressed in 35 cases (54.7%). Twenty-four (68.6%) of 35 cases with HRad17 overexpression in cancer tissues were node-positive, whereas only 8 (27.6%) of 29 cases without HRad17 overexpressions were node-positive. The expression of HRad17 mRNA correlated with both lymph node metastasis (P = 0.001) and high Ki67 labeling index (P = 0.006). Although not significantly different, expression of HRad17 mRNA tended to correlate with tumor size (P = 0.06) and expression of mutant p53 protein (P = 0.10). Furthermore, expression of HRad17 mRNA was an independent predictor of axillary lymph node metastasis as well as of lymphatic permeation by multivariate analysis (P < 0.0001). Conclusions: Our study demonstrates that HRad17 might be related to the development of lymph node metastasis in human breast cancers. Although its function still remains unclear, the expression of HRad17 mRNA could open up a new window for the diagnostic staging and treatment of human breast cancers.

UR - http://www.scopus.com/inward/record.url?scp=0034813251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034813251&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 2815

EP - 2820

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 9

ER -